SCHEMBL28049087

SCHEMBL28049087

[CH2]CC(O)c1cccc(C#Cc2cccnc2)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 5/20 0.43
▸ CYP2C9 P11712 3/20 0.43
▸ CYP2B6 P20813 3/20 0.43
▸ CYP2C19 P33261 3/20 0.43
▸ CYP2E1 P05181 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C8 P10632 1/20 0.42
▸ ERN1 O75460 1/20 0.41
▸ PTGES O14684 2/20 0.41
▸ CHRNB2 P17787 5/20 0.41
▸ CHRNA4 P43681 5/20 0.41
▸ GRM5 P41594 1/20 0.41
▸ FFAR1 O14842 1/20 0.41
▸ AKR1C3 P42330 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HAO1 Q9UJM8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16030670 0.83 CYP2A6 (0.48) CYP2A6CYP2C9CYP2B6CYP2C19CYP2E1
SCHEMBL7629318 0.78 SMN1; SMN2 (0.55) SMN1; SMN2
SCHEMBL16031499 0.77 PTGES (0.45) CYP2A6CYP2C9CYP2B6CYP2C19PTGES
SCHEMBL16151063 0.75 CYP2A6 (0.44) CYP2A6CYP2C9CYP2B6CYP2C19CYP2E1
SCHEMBL28825667 0.74 CYP2A6 (0.41) CYP2A6GRM5
SCHEMBL3796332 0.72 CYP2A6 (0.67) CYP2A6CYP2C9CYP2B6CYP2C19CYP2E1
SCHEMBL30963914 0.72 CYP2A6 (0.50) CYP2A6CYP2C9CYP2B6CYP2C19CYP2E1
SCHEMBL2806200 0.72 CYP2A6 (0.50) CYP2A6CYP2C9CYP2B6CYP2C19CYP2E1
SCHEMBL2842557 0.69 HDAC4 (0.53) PTGESFFAR1AKR1C3HAO1
SCHEMBL9132515 0.69 SMN1; SMN2 (0.53) CYP2A6CYP2C9CYP2B6CYP2C19CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105209428-A Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders ACUCELA INC 2015-12-30 — — CN disclosed
Send feedback